Scientific Program

Scientific Program

The 14th World Stroke Congress will bring the latest science, clinical trials and guidelines to
stroke prevention, treatment, rehabilitation, and support, from every part of the globe.

Program Highlights

Debate 1

Presentation Titles:

  • Should intra-arterial thrombolysis be considered following mechanical thrombectomy with suboptimal recanalization?
  • Mechanical thrombectomy for patients with large infarcts (Aspects 3-5), Yay or Nay?

 

Debate 2

Presentation Titles:

  • Is perfusion imaging for decision making for reperfusion treatment in patients with large vessel obstruction in the late time window essential or not worth the hassle?
  • Low-dose alteplase for stroke thrombolysis- is the clinical role defined?

 

Debate 3

Presentation Titles:

  • Should patients on a direct oral anticoagulant within the last 48 hours be excluded from thrombolysis, or should testing and reversal be considered?

 

Debate 4

Presentation Titles:

  • A single covert brain infarction – an incidental finding or opportunity for prevention?
  • Should double antiplatelet be given routine for a short period for all non-AF ischemic stroke patients? (DAPT)?

 

Debate 5

Presentation Titles:

  • Which is the better strategy for primary and secondary stroke prevention- Tailored to the individual or use of polypill concept?
  • Is medical treatment enough for patients with asymptomatic severe cervical carotid stenosis?

 

Debate 6

Presentation Titles:

  • Left atrial appendage closure is the main treatment option for patients with AF who has a stroke despite optimal anticoagulation? anticoagulant?

Stroke in the COVID-19 pandemic

Presentation Titles:

  • Pathophysiology and outcomes of stroke associated with COVID-19 infection
  • Impact of COVID-19 on stroke care- early experience from the breakout in Wuhan
  • Hyperacute recanalization stroke treatments in COVID-19 patients
  • Stroke rehabilitation in a pandemic – Limitations and opportunities

 

Diagnostic and Predictive Biomarkers in Stroke and Cognitive Impairment

Presentation Titles:

  • The role of biomarkers in acute stroke management
  • Biomarkers to guide secondary stroke prevention
  • Biomarkers of high-risk carotid and intracranial atherosclerosis
  • Biomarkers and the risk of dementia

 

Latest approaches to ICH management

Presentation Titles:

  • Comparison of 2022 ICH guideline: ESO and AHA/ASA
  • Latest data on blood pressure management in ICH
  • Advances in neurosurgical ICH approaches
  • Recent issues of oral anticoagulant associated ICH
  • Anticoagulation after ICH – considerations for patients with AF, cerebral microbleeds and others

 

Advance in Intracranial Artery Stenosis (ICAS) and Clinical Practice

Presentation Titles:

  • Stroke syndromes and mechanisms related to ICAS
  • Advances in imaging for ICAS
  • Hyperacute treatment for stroke-related to ICAS
  • Secondary prevention for stroke secondary to ICAS

 

Retrieving the clot – achieving the task 

Presentation Titles:

  • Aspiration versus Stent Retriever Thrombectomy – When to use which?
  • How clot imaging could help thrombectomy?
  • Thrombectomy-resistant large vessel obstruction stroke- tricks and tips
  • Adjunctive Intra-arterial thrombolysis optimizing reperfusion

 

New Avenues for Secondary stroke prevention

Presentation Titles:

  • Factor XIa inhibition: what is the rational in context of secondary stroke prevention
  • Lp(a) a new potentially treatable target in secondary stroke prevention
  • Intensive lipid control and tighter target levels for secondary stroke prevention
  • Anti-inflammatory targets for secondary stroke prevention

 

Updates on stroke primary and secondary prevention

Presentation Titles:

  • Antiplatelets including role of dual antiplatelet therapy
  • Anticoagulation and device therapy for structural heart disease
  • Carotid disease- medical management and carotid intervention
  • Blood pressure control: Is intensive lowering necessary?

 

Disparities in stroke epidemiology and care

Presentation Titles:

  • Stroke in Women: What we all should know in 2022
  • Racial and ethnic disparities in stroke: novel insights
  • Digital health innovations to reduce inequities in stroke
  • Impact of country and region economic status

 

Hyper-acute therapies of ischemic stroke

Presentation Titles:

  • Intravenous thrombolysis prior to mechanical thrombectomy- a critical review of the evidence
  • Lesson learnt from meta-analysis of RCT for thrombolysis and mechanical thrombectomy
  • Intravenous thrombolysis prior to mechanical thrombectomy: Application in the real world.

Joint Session with World Health Organization (WHO) – Salient Considerations for Implementation of interventions for reducing the global burden of stroke.

Presentation Titles:

  • Policy and Pragmatic Solutions to improve global surveillance of stroke and its risk factors
  • Policy and Pragmatic Solutions to improve Primary and Secondary Prevention of stroke
  • Policy and Pragmatic Solutions to improve hyperacute and acute stroke care
  • Policy and Pragmatic Solutions to improve rehabilitation and re-integration of stroke survivors
  • Discussion: Bringing these elements together for scaling up stroke prevention and control globally

 

Joint Session with World Federation of Neurology (WFN) – Challenges in Stroke Education

Presentation Titles:

  • Challenges of stroke education in African- WFN needs registry
  • Regional differences in stroke education, training, and awareness
  • World Stroke Academy Activities and Special Projects
  • The Future Stroke Leaders programme
  • Family centred post stroke education: primary and secondary prevention.

 

Joint Session with World Hypertension League (WHL) – The Global Use of Stroke as an Indicator of Population Hypertension Control

Presentation Titles:

  • Stroke and Hypertension Outcomes in Sub-Saharan Africa
  • Stroke and Hypertension Outcomes in Brazil and South America
  • Stroke and Hypertension Outcomes in Asia
  • Roadmap and overall global plan for hypertension

 

Joint Session with Chinese Stroke Association (CSA) – Reperfusion strategies for stroke

Presentation Titles:

  • Advances of Tenecteplase treatment for reperfusion

  • TRACE trials: Tenecteplase reperfusion therapy in acute ischemic cerebrovascular events I, II, and III
  • Automated stroke perfusion evaluation software
  • A topic on endovascular therapy (title pending)

 

Joint Session with The Association of Southeast Asian Nations Neurological Association (ASNA) – Stroke patterns and issues in Asian

Presentation Titles:

  • Stroke and infections
  • Thrombolysis and small vessel disease
  • Clopidogrel resistance in secondary stroke prevention
  • Radiation associated carotid disease